Insights from analysts' 12-month price targets are revealed, presenting an average target of $51.3, a high estimate of $61.00, and a low estimate of $31.00. A 14.64% drop is evident in the current ...

Bluebird has reaffirmed its support for a proposed acquisition after Ayrmid failed to deliver a binding offer by the extended ...

What sets Google apart, in its own words, is the tight integration of its foundation models across its entire stack. Much like Oracle Corp.’s longstanding advantage from integrating software with ...

The latest advances and the future of Google Cloud Platform and cloud computing in general are on display at Google Cloud Next ’25 (April 9-11, in Las Vegas).

Johnson & Johnson’s Joaquin Duato is no longer the highest paid CEO in pharma. Meanwhile, just two women make the top 10.

Uncanny yet tender sculptures that speak to their creator's own mortality pop up at Altman Siegel Pacific Heights.

The feature is described as an ‘experiment’ that’s taking place in Australia and the UK.

"Dreamboy" singer-songwriter Lil Nas X told fans on April 14 that he had “lost control” of the right side of his face Emily Blackwood is a writer and editor at PEOPLE. She has been working at ...

Trump orders multi-part executive order to lower drug prices, reduce Medicare costs. Includes guidance on Medicare drug ...

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...